Loading...
NPI 1962053421 · Milwaukee, WI · Community/Retail Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Hayat Pharmacy 19 LLC is a community/retail pharmacy provider located in Milwaukee, Wisconsin. This profile covers 9 Medicare and 7 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Hayat Pharmacy 19 LLC |
| Address | 807 W Layton Ave Ste A |
| City | Milwaukee |
| State | WI |
| ZIP | 53221 |
| Taxonomy | Community/Retail Pharmacy |
| NPI Enumerated | September 26, 2019 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $178.9K |
| Medicaid | $9.7K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
9 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 540 | $140 | $76.5K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 440 | $80 | $33.3K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 670 | $40 | $26K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 130 | $130 | $16.8K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 1,030 | $10 | $12.4K |
| G0008 | Administration of influenza virus vaccine | 470 | $10 | $6.6K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 20 | $280 | $5.9K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 30 | $20 | $750 |
| G0009 | Administration of pneumococcal vaccine | 20 | $30 | $670 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 9 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
7 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99605 | The pharmacist provides a 15–minute, in–person, patient–specific medication evaluation for a new patient based on factors such as the patient’s history and medication list. | 110 | $40 | $4K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 20 | $140 | $2.3K |
| 99606 | The pharmacist provides a 15–minute, in–person, patient–specific medication evaluation for an established patient based on factors such as the patient’s history and medication list. | 40 | $30 | $1.3K |
| 90656 | This code represents a preservative–free trivalent influenza vaccine product containing split virus components. It is administered into the muscle in a 0.5 mL dosage. | 60 | $20 | $1K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 30 | $30 | $990 |
| 99607 | After an initial 15 minutes, the pharmacist provides an additional 15–minutes of an in–person, patient–specific medication evaluation for a patient based on factors such as the patient’s history and… | 50 | $0 | $0 |
| G0008 | Administration of influenza virus vaccine | 60 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Wisconsin providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Wisconsin median
7 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99605 | The pharmacist provides a 15–minute, in–person, patient–specific medication evaluation for a new patient based on factors such as the patient’s history and medication list. | 15 | 40 | 70 | $60 | $15.4K |
| 99606 | The pharmacist provides a 15–minute, in–person, patient–specific medication evaluation for an established patient based on factors such as the patient’s history and medication list. | 14 | 30 | 50 | $40 | $10K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 99 | 130 | 30 | $80 | $8K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 52 | 80 | 40 | $20 | $4K |
| 90656 | This code represents a preservative–free trivalent influenza vaccine product containing split virus components. It is administered into the muscle in a 0.5 mL dosage. | 83 | 210 | 40 | $10 | $2.2K |
| G0008 | Administration of influenza virus vaccine | 109 | 190 | 90 | $1 | $900 |
| 99607 | After an initial 15 minutes, the pharmacist provides an additional 15–minutes of an in–person, patient–specific medication evaluation for a patient based on factors such as the patient’s history and… | 12 | 20 | 60 | $1 | $170 |
Other providers in the same ZIP code as Hayat Pharmacy 19 LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.